UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $90.00

by · The Markets Daily

Colgate-Palmolive (NYSE:CL – Free Report) had its price objective reduced by UBS Group from $92.00 to $90.00 in a report issued on Monday,Benzinga reports. UBS Group currently has a buy rating on the stock.

CL has been the subject of several other reports. Barclays cut their price objective on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Citigroup cut their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Bank of America cut their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research report on Monday. Nine equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $89.87.

Get Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.5%

Colgate-Palmolive stock opened at $76.91 on Monday. The stock has a 50-day simple moving average of $79.96 and a 200 day simple moving average of $85.94. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The stock has a market capitalization of $62.16 billion, a P/E ratio of 21.60, a PEG ratio of 4.44 and a beta of 0.35. Colgate-Palmolive has a 52 week low of $74.54 and a 52 week high of $100.18.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period last year, the business posted $0.91 earnings per share. Analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.26%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Westside Investment Management Inc. raised its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares in the last quarter. Cornerstone Planning Group LLC grew its stake in shares of Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares during the last quarter. Saudi Central Bank bought a new stake in shares of Colgate-Palmolive during the first quarter worth $29,000. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive during the third quarter worth $29,000. Finally, Vermillion & White Wealth Management Group LLC grew its stake in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More